Logo - springer
Slogan - springer

Medicine - Cardiology & Angiology | Journal of Cardiovascular Translational Research – incl. option to publish open access (Press)

Journal of Cardiovascular Translational Research

Journal of Cardiovascular Translational Research

Editor-in-Chief: Jennifer L. Hall

ISSN: 1937-5387 (print version)
ISSN: 1937-5395 (electronic version)

Journal no. 12265

New York / Heidelberg, 4 March 2013

Obesity, age and your heart – is it too late to go on a diet?

Study finds that the protective cardiac effects of calorie restriction benefit the young but not the old in mice

Two major risk factors for heart disease are obesity and age, with increases in both being detrimental to the heart. Recent studies in humans have found that restricting calorie intake can have profound heart benefits in obese adults with improvements seen in both heart structure and function. However, the exact mechanisms involved and the relationships between the effects of obesity and aging are not clear.
A new study published in Springer’s Journal of Cardiovascular Translational Research helps to clarify some of these issues. Majd AlGhatrif from the Johns Hopkins University School of Medicine in Baltimore and his colleagues looked at whether the protective effects of caloric restriction would still apply in leptin-deficient obese mice and further whether these effects were similar in different age groups. Leptin is a hormone produced by the fat cells that triggers the sense of feeling full. Deficiency of this hormone causes overeating and obesity.
The researchers studied the effects of caloric restriction in two-month-old versus six- to seven-month-old leptin-deficient obese mice. Both young and old mice lost a similar amount of weight on the restricted diet. In the younger mice, restricting calories was found to have several positive effects on the heart. As well as restoring normal heart stiffness (diastolic function), it helped reverse the amount of fat deposited in the heart cells and helped normalize cellular processes in the heart. None of these benefits were seen in the older mice.
However, the team discovered that although fat deposition in the hearts of the older mice did not change, caloric restriction reduced the negative effects of this fat on the heart tissue. Thus, the mice should have been better able to repair the free radical cellular damage inflicted by the fat deposits. Surprisingly, this did not lead to an improvement in heart function in older mice, indicating that the oxidative damage had reached a point where it had become irreversible. Exactly when this point is reached is not currently known.
AlGhatrif and his colleagues conclude that “discovering the exact mechanism of reversibility and determining what ultimately can reduce the persistent oxidative damage and diastolic dysfunction will greatly enhance our understanding of the physiology of cardiovascular aging.” They add that many aspects of their research warrant further study in order to fully elucidate exactly when oxidative damage gets to the stage where caloric restriction will no longer be able to normalize heart function.
AlGhatrif M et al. (2013) Beneficial cardiac effects of caloric restriction are lost with age in a murine model of obesity. Journal of Cardiovascular Translational Research. DOI 10.1007/s12265-013-9453-4
The full-text article is available to journalists on request.




For authors and editors

  • Journal Citation Reports®, Thomson Reuters
    2013 Impact Factor
  • 2.691
  • Aims and Scope

    Aims and Scope


    Journal of Cardiovascular Translational Research (JCTR) is a premier journal in cardiovascular translational research.

    JCTR is the journal of choice for authors seeking the broadest audience for emerging technologies, therapies and diagnostics, pre-clinical research, and first-in-man clinical trials.

    JCTR's intent is to provide a forum for critical evaluation of the novel cardiovascular science, to showcase important and clinically relevant aspects of the new research, as well as to discuss the impediments that may need to be overcome during the translation to patient care.

    JCTR encourages submission  of original articles, reports on study designs, and review articles. 

    • Authors receive a decision within 10 days, on average
    • Fast OnlineFirst publication ahead of print
    •For more information including details on article submission, please visit http://www.springer.com/medicine/cardiology/journal/12265

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Conflict of Interest Form (pdf, 494 kB)
  • Instructions for Authors

    Instructions for Authors


  • Author Academy: Training for Authors
  • Novel Images and Video Clips

    Call for novel images and video clips


  • Copyright information

    Copyright information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer Science+Business Media New York

Alerts for this journal


Get the table of contents of every new issue published in Journal of Cardiovascular Translational Research.